bronchoprovocation
Showing 1 - 25 of 62
Bronchial Asthma Trial in Medford (Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation), Ventolin HFA 90Mcg/Actuation
Not yet recruiting
- Bronchial Asthma
- Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation)
- +3 more
-
Medford, OregonVelocity CLinical Research
Nov 23, 2023
Mild Asthma Trial in New Taipei City (Albuterol Sulfate inhalation aerosol 108 mcg per actuation, Proair HFA (Albuterol Sulfate)
Not yet recruiting
- Mild Asthma
- Albuterol Sulfate inhalation aerosol 108 mcg per actuation
- +4 more
-
New Taipei City, TaiwanClinical Pharmacology Unit,Mackay Memorial Hospital
Jun 3, 2021
Asthma Trial in Lexington (Segmental Bronchoprovocation with Allergen (SBP-Ag))
Withdrawn
- Asthma
- Segmental Bronchoprovocation with Allergen (SBP-Ag)
-
Lexington, KentuckyUniversity of Kentucky Medical Center, Center for Clinical and T
Dec 5, 2020
Mild Persistent Asthma Trial in United States (methacholine chloride, ProAir HFA, ProAir HFA)
Completed
- Mild Persistent Asthma
- methacholine chloride
- +4 more
-
Huntington Beach, California
- +16 more
Nov 20, 2020
Asthma Trial in Madison (mannitol)
Completed
- Asthma
-
Madison, WisconsinUniversity of Wisconsin Madison Department of Asthma, Allergy an
Aug 14, 2019
Mechanisms of Exercise-induced Bronchospasm
Completed
- Exercise-induced Bronchospasm
-
Columbus, OhioThe Ohio State University
Oct 28, 2021
Bronchial Asthma Trial in Denver (90 mcg Reference Product, 180 mcg Reference Product, 90 mcg Test Product)
Completed
- Bronchial Asthma
- 90 mcg Reference Product
- +3 more
-
Denver, ColoradoColorado Allergy and Asthma Centers
Jul 23, 2019
Bronchial Asthma Trial in San Jose (Methacholine Chloride, Albuterol Sulfate HFA 0.09 mg (Reference), Albuterol Sulfate HFA 0.18
Withdrawn
- Bronchial Asthma
- Methacholine Chloride
- +5 more
-
San Jose, CaliforniaInvestigational site #1
May 16, 2022
Airway Hyper Responsiveness Trial in Saskatoon (Volumetric methacholine challenge unmodified, Modified volumetric methacholine
Completed
- Airway Hyper Responsiveness
- Volumetric methacholine challenge unmodified
- Modified volumetric methacholine challenge
-
Saskatoon, Saskatchewan, CanadaAsthma Research Lab - University of Saskatchewan
Mar 25, 2020
Idiopathic Pulmonary Fibrosis, Idiopathic Interstitial Pneumonia, Interstitial Lung Diseases Trial in Worldwide (patient
Recruiting
- Idiopathic Pulmonary Fibrosis
- +3 more
- patient registry (observation and biomaterial sampling)
-
Vienna, Austria
- +6 more
Nov 2, 2021
Asthma, Genotype Trial in Indianapolis (Slow Release DHEA)
Recruiting
- Asthma
- Genotype
- Slow Release DHEA
-
Indianapolis, Indiana
- +1 more
Jan 19, 2023
Asthma Trial in Brookhaven (Placebo, 90 mcg Reference Product, 180 mcg Reference Product)
Unknown status
- Asthma
- Placebo
- +3 more
-
Brookhaven, New YorkAmneal Pharmaceuticals LLC
Jun 13, 2018
Airway Remodeling and Rhinovirus in Asthmatics
Recruiting
- Asthma
- Respiratory Disease
- HRV-39
-
Calgary, Alberta, CanadaUniversity of Calgary
Mar 7, 2023
Asthma, Cough Variant Asthma Trial in Kingston (high-dose methacholine challenge test, mannitol challenge test)
Completed
- Asthma
- Cough Variant Asthma
- high-dose methacholine challenge test
- mannitol challenge test
-
Kingston, Ontario, CanadaKingston General Hospital
Feb 9, 2022
Asthma in Children Trial in Lesko (asthma treatment adjustment taking account on degree of bronchial hyperresponsiveness)
Completed
- Asthma in Children
- asthma treatment adjustment taking account on degree of bronchial hyperresponsiveness
-
Lesko, PolandThe Regional Public Hospital in Lesko, Poland
Aug 11, 2020
Biomarkers, Airway Inflammation Trial in Guangzhou (no intervention)
Not yet recruiting
- Biomarkers
- Airway Inflammation
- no intervention
-
Guangzhou, Guangdong, ChinaGuangzhou Institute of Respiratory health
May 12, 2021
Exercise Induced Bronchospasm, Athletes, Adolescent Trial in Leuven (EVH test)
Active, not recruiting
- Exercise Induced Bronchospasm
- +2 more
- EVH test
-
Leuven, Vlaams-Brabant, BelgiumUniversity Hospital of Leuven
Nov 4, 2021
Severe Asthma Trial in Larissa (Mepolizumab)
Recruiting
- Severe Asthma
- Mepolizumab
-
Larissa, Thessaly, GreeceExternal Unit of Asthma of Respiratory Medicine Department of th
Nov 23, 2021
Epithelial Barrier Integrity in Biologic Treatment Response of
Not yet recruiting
- Severe Eosinophilic Asthma w/wo CRSwNP
- Mepolizumab 100 MG
-
Heraklion, Crete, Greece"PAGNI" University Hospital, Crete
May 3, 2022
Asthma Trial in Hamilton, Québec City, Saskatoon (Wright jet nebulizer, Aerogen Solo)
Completed
- Asthma
- Wright jet nebulizer
- Aerogen Solo
-
Hamilton, Ontario, Canada
- +2 more
Dec 9, 2019